GABY Inc. Announces Strong Demand in Respect of Equity Financing and Appoints Javier Estades to Board of Directors
SANTA ROSA, CA / ACCESSWIRE / January 8, 2021 / GABY Inc. (
GABY or the
Company ) (CSE:GABY)(OTCQB:GABLF), a California based cannabis and consumer products company redefining the future of cannabis retail, is pleased to announce that its private placement of subscription receipts (the
Private Placement ) led by Mackie Research Capital Corporation has generated indications from investors in excess of the announced C$11.0 million and, as such, the Company will proceed to close the Private Placement on or about January 18
th, 2021. Proceeds from the Private Placement will be used to fund the previously announced merger (the
Thanks to
biotech-focused drug development, the emerging psychedelic industry is stronger than ever before. However, there is a hidden hero in the details of the
numerous press releases pertaining to psychedelic medicine progress – the investment banks allowing this space to grow. Indeed, the sheer scale of psychedelic medicine’s agenda requires a lot of funding, and much of this funding is thanks to investment banks who enter agreements with psychedelic medicine companies. Though there is an obvious mutually beneficial opportunity for both sides of
psychedelic investment, the banks are still taking on a relative area of risk. But by doing so, they are simultaneously making it less risky, more financially stable, and of course, more lucrative for investors.
Platinex Completes Oversubscribed Flow Through Private Placement
Platinex Inc. is pleased to announce that it has completed its previously announced non-brokered private placement issuing a total of 11,430,338 flow-through units for gross proceeds of $857,275. Each FT Unit consists of one flow-through common share of the Company and one half of one common share purchase warrant. Each full warrant is exercisable into a non-flow through common share at an exercise price of $0.10 …
Platinex Inc. (CSE: PTX) (the ” Company ” or ” Platinex “) is pleased to announce that it has completed its previously announced non-brokered private placement (the ” Private Placement “), issuing a total of 11,430,338 flow-through units (” FT Units “) for gross proceeds of $857,275. Each FT Unit consists of one flow-through common share (” FT Share “) of the Company and one half of one common share purchase warrant. Each full warrant (” Warrant “) is exercisable into a non-flow th
NeonMind Biosciences Inc: NeonMind Announces Closing of Oversubscribed Initial Public Offering and Exercise in Full of the Agent s Over-Allotment Option NeonMind Biosciences Inc.
completed the maximum offering for its initial public offering (the
IPO ) of 46,000,000 units of NeonMind (the
Units ) at a price to the public of $0.10 per Unit, including 6,000,000 in additional Units pursuant to the exercise in full of the over-allotment option. The gross proceeds from the IPO, before deducting agent fees and estimated offering expenses, were $4.6 million. NeonMind s common shares were listed on the Canadian Securities Exchange (the
Exchange ) on December 29, 2020 and were immediately halted pending the closing of the IPO. Trading of NeonMind s common shares on the Exchange will resume at market open on Monday, January 4, 2021 under the ticker symbol
JNC Resources Year-End Review
VANCOUVER, BC / ACCESSWIRE / December 31, 2020 / JNC Resources Inc. (CSE:JNC) ( JNC or the Company ) is pleased to reflect on a very successful 2020. JNC completed its initial public offering on the Canadian Securities Exchange in April 2020 with Mackie Research Capital Corporation acting as the agent. Subsequently, the Company completed international listings on both the US Markets (OTC PINK:JNCCF) and in Germany (Frankfurt:5VH). JNC firmly believes that by listing on these three exchanges, it increases the Company s overall market presence and shareholder awareness as a growing global exploration company.
JNC was incorporated with its Triple 9 project in British Columbia. The Triple 9 Property consists of 2 mineral claims covering approximately 717 hectares, 6 km northwest of Sicamous, British Columbia. The Company carried out an initial exploration program in May, 2019, where we were able to complete a very successful geochemical survey before COV